|
- NIH FAQs - UW Research
NIH FAQs Updated 7 17 2025 Follow up on reinstatements: OSP prepared and sent customized emails to NIH about award reinstatements Please review the 7 08 2025 announcement shared with MRAM on this topic NIH Terminated Awards – Reinstatement Q1: My NIH award was terminated and will be reinstated Do I need to do anything to reinstate my NIH
- FAQs | Student Financial Aid
University of WashingtonHow long does it take for you to review information I sent in for my preliminary aid offer or request to revise my aid?
- FAQs - Accessibility at the UW
FAQs Common questions and answers about disability accommodations across university environments What is a disability? According to the Americans with Disabilities Act and Washington State Law, a disability is a physical or mental impairment that substantially limits one or more major life activities
- Bridge Funding Program FAQs - UW Research
Bridge Funding Program FAQs Application Process Do I need to route the application for the bridge funding through sign-off with an eGC1? You don’t need an eGC1 to request bridge funding Should the documentation of the match commitment and the budget for the match be approved and signed by the college school of the applicant PI?
- Rule Guidance and FAQs – Office of the ADA Coordinator
Curious about the new digital accessibility rule? Explore our Guidance and Frequently Asked Questions (FAQs) below This page continually updates as new questions come in to the Office of the ADA
- FAQs | Data Science Masters
Join one of the leading data science programs in the nation and accelerate your high-tech career in data science
- Zipline FAQs - UW Research
Zipline FAQs Print See the topic pages below to access many frequently asked questions about Zipline If you are unable to find the answer to your question, contact the HSD team that reviews for your department or hsdinfo@uw edu for help
- New Industry Clinical Trial Definition and F A Rate . . . - UW Homepage
Frequently-Asked Questions New Industry Clinical Trial Definition and F A Rate Effective July 1st Q1: I am talking with a company about running a clinical trial and will start the process in REDCap ahead of eGC1 routing Should I use the 35% rate now, since I am submitting budget related information to CTO and talking to the sponsor? A1: Use the 35% TDC rate if you plan on routing the eGC1 on
|
|
|